Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Metered Cryospray for the Treatment of Patients With Chronic Obstructive Pulmonary Disease With Chronic Bronchitis

NCT: NCT03892694 · COMPLETED

NCT IDNCT03892694
StatusCOMPLETED
Start Date2020-02-14
Completion2022-12-12
SponsorCSA Medical, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

To evaluate the relationship between airway structure and function in patients with chronic bronchitis treated with metered cryospray (MCS).

Frequently Asked Questions

What is Metered Cryospray for the Treatment of Patients With Chronic Obstructive Pulmonary Disease With Chronic Bronchitis?

Metered Cryospray for the Treatment of Patients With Chronic Obstructive Pulmonary Disease With Chronic Bronchitis is a clinical trial registered under NCT03892694. Current status: COMPLETED.

What is the status of NCT03892694?

The current status of NCT03892694 (Metered Cryospray for the Treatment of Patients With Chronic Obstructive Pulmonary Disease With Chronic Bronchitis) is: COMPLETED.

When did Metered Cryospray for the Treatment of Patients With Chronic Obstructive Pulmonary Disease With Chronic Bronchitis start?

Metered Cryospray for the Treatment of Patients With Chronic Obstructive Pulmonary Disease With Chronic Bronchitis started on 2020-02-14.

Related Devices

K161557truFreeze SystemCSA Medical, Inc. K162695truFreeze SystemCSA Medical, Inc. K163244truFreeze SystemCSA Medical, Inc. K171522truFreeze Rapid AV Spray KitCSA Medical, Inc. K171626truFreeze SystemCSA Medical, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑